IMMUNITYBIO, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IMMUNITYBIO, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $35.33M.
- IMMUNITYBIO, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $269.99M.
- IMMUNITYBIO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $188.54M, a 30.17% decline from fiscal 2023.
- IMMUNITYBIO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $269.99M, a 419.74% increase from fiscal 2022.
- IMMUNITYBIO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $51.95M.
- IMMUNITYBIO, INC. stock issued during period, value, conversion of convertible securities for fiscal 2015 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-03-31 | $35.33M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $188.54M 10-K · filed 2026-02-23 | |
| 2023-12-31 | $269.99M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $269.99M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $51.95M 10-K · filed 2025-03-03 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |